OTCMKTS:CLPBY

Coloplast A/S (CLPBY) Stock Price, News & Analysis

Coloplast A/S logo
$7.46 -0.03 (-0.40%)
As of 03:58 PM Eastern

About Coloplast A/S Stock (OTCMKTS:CLPBY)

Advanced

Key Stats

Today's Range
$7.45
▼
$7.54
50-Day Range
$6.18
▼
$7.92
52-Week Range
$5.64
▼
$9.29
Volume
53,749 shs
Average Volume
322,615 shs
Market Capitalization
$16.81 billion
P/E Ratio
18.67
Dividend Yield
1.07%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Coloplast A/S is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care.

Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.

Founded in Denmark in 1957, Coloplast serves customers in markets around the world. The company was established after nurse Elise Sørensen helped develop an ostomy bag for her sister, in collaboration with entrepreneur Aage Louis-Hansen.

AI Generated. May Contain Errors.

Coloplast A/S Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

CLPBY MarketRank™: 
3.862068965515 of 5 stars

Coloplast A/S scored higher than 77% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Coloplast A/S has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 2 strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Coloplast A/S has only been the subject of 1 research reports in the past 90 days.

  • Read more about Coloplast A/S's stock forecast and price target.
  • Earnings Growth

    Earnings for Coloplast A/S are expected to grow by 10.81% in the coming year, from $0.37 to $0.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Coloplast A/S is 18.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.70.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Coloplast A/S is 18.67, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.43.

  • Price to Earnings Growth Ratio

    Coloplast A/S has a PEG Ratio of 3.54. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Coloplast A/S has a P/B Ratio of 7.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.01% of the float of Coloplast A/S has been sold short.
  • Short Interest Ratio / Days to Cover

    Coloplast A/S has a short interest ratio ("days to cover") of 0.51, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Coloplast A/S has recently decreased by 89.72%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Coloplast A/S pays a meaningful dividend of 1.13%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Coloplast A/S does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Coloplast A/S is 38.10%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Coloplast A/S will have a dividend payout ratio of 19.51% next year. This indicates that Coloplast A/S will be able to sustain or increase its dividend.

  • Read more about Coloplast A/S's dividend.
  • News Sentiment

    Coloplast A/S has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Coloplast A/S this week, compared to 0 articles on an average week.
Receive CLPBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLPBY Stock News Headlines

Analyzing Omnicell (NASDAQ:OMCL) and Coloplast A/S (OTCMKTS:CLPBY)
A $247 tool for $7
Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel
Coloplast A/S (CLPBY) Q4 2026 Earnings Call Transcript
CLPBY Share News Today
See More Headlines

CLPBY Stock Analysis - Frequently Asked Questions

Coloplast A/S's stock was trading at $8.50 on January 1st, 2026. Since then, CLPBY stock has decreased by 12.2% and is now trading at $7.46.

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) announced its quarterly earnings results on Tuesday, November, 3rd. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.00. The firm had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a trailing twelve-month return on equity of 42.25% and a net margin of 10.57%.

Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Coloplast A/S investors own include Advanced Micro Devices (AMD), ASML (ASML), Broadcom (AVGO), GDS (GDS), Citigroup (C), Delta Air Lines (DAL) and GE Aerospace (GE).

Company Calendar

Last Earnings
11/03/2026
Today
11/16/2026
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:CLPBY
Previous Symbol
NASDAQ:CLPBY
CIK
1294325
Fax
N/A
Employees
17,156
Year Founded
1957

Profitability

EPS (Trailing Twelve Months)
$0.21
Trailing P/E Ratio
18.67
Forward P/E Ratio
18.20
P/E Growth
3.54
Net Income
$478.04 million
Net Margins
10.57%
Pretax Margin
13.97%
Return on Equity
42.25%
Return on Assets
11.87%

Debt

Debt-to-Equity Ratio
1.51
Current Ratio
1.56
Quick Ratio
0.94

Sales & Book Value

Annual Sales
$4.50 billion
Price / Sales
3.74
Cash Flow
$0.37 per share
Price / Cash Flow
20.30
Book Value
$1.06 per share
Price / Book
7.04

Miscellaneous

Outstanding Shares
2,253,670,000
Free Float
N/A
Market Cap
$16.81 billion
Optionable
Not Optionable
Beta
0.10

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:CLPBY) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners